911140-85-7Relevant academic research and scientific papers
COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY
-
Page/Page column 55, (2019/04/11)
Compounds, and compositions, methods, and uses thereof, are described herein for treating brain injuries.
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
-
Page/Page column 54-55, (2015/12/23)
Compounds, and compositions, methods, and uses thereof, are described herein for treating neurodegenerative diseases and disorders. In particular, vasopressin receptor modulators, and compositions, methods and uses thereof, are described herein for treati
METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER
-
Page/Page column 47, (2012/01/15)
Compounds and compositions are described herein for treating post tramatic stress disorder.
BETA-LACTAM CANNABINOID RECEPTOR MODULATORS
-
Page/Page column 84, (2008/06/13)
Described herein are substituted 2-(azetidin-2-on-l-yl)alkanoic acids, alkanedioic acids and 2-hydroxyalkyl alkanoic acids, and 2-acyl alkanoic acids, and derivatives thereof, that are capable of modulating activity at the cannabinoid-1 (CBl) and/or canna
HYDROXY AND KETO-SUBSTITUTED β-LACTAMYL ALKANEDIOIC ACIDS
-
Page/Page column 49, (2010/11/28)
3-Hydroxy and 3-keto substituted 2-(azetidin-2-on-l-yl)alkanedioic acids, and analogs and derivatives thereof are described. Methods for using 3-hydroxy and 3-keto substituted 2-(azetidin-2-on-l-yl)alkanedioic acids, and analogs and derivatives thereof, i
β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
-
, (2010/11/28)
β-lactamyl alkanoic acids and pharmaceutical compositions thereof are described. Methods for treating various diseases and disease states using one or more β-lactamyl alkanoic acids are also described. Substituted 2-(azetidin-2-on-l-yl)alkanedioic acids,
BETA-LACTAMYLALKANOIC ACIDS FOR TREATING PREMENSTRUAL DISORDERS
-
Page/Page column 22-23, (2008/06/13)
0-lactamyl alkanoic acids are described. Methods for treating various premenstrual disorders using or more β-lactamyl alkanoic acids are also described.
3-SUBSTITUTED β-LACTAMYL VASOPRESSIN V1A ANTAGONISTS
-
Page/Page column 41-42, (2008/06/13)
Novel 2-(azetidin-2-on-1-yl)alkanedioic acids and derivatives thereof are described. Methods for using 2-(azetidin-2-on-l-yl)alkanedioic acids and derivatives thereof in the treatment of disease states responsive to antagonism of the vasopressin V1a
On the question of the diastereoselective alkylation of 4-unsubstituted 3-amino β-lactams. A concise synthesis of α-branched α-amino β-lactams and their coupling with α-amino acid esters
Palomo, Claudio,Aizpurua, Jesus M.,Galarza, Regina,Benito, Ana,Khamrai, Uttam K.,Eikeseth, Unni,Linden, Anthony
, p. 5563 - 5570 (2007/10/03)
The reaction of [(4S)-2-oxo-4-phenyloxazolidin-3-yl]acetic acid chloride with N-methylidene-bis-[(trimethylsilyl)methyl]amine and triethylamine in refluxing chloroform leads to a 4-unsubstituted β-lactam able to undergo highly asymmetric alkylations at th
